These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8319726)

  • 1. The long-term outcome of patients with glycogen storage disease type Ia.
    Smit GP
    Eur J Pediatr; 1993; 152 Suppl 1():S52-5. PubMed ID: 8319726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric drip feeding in patients with glycogen storage disease type I: its effects on growth and plasma lipids and apolipoproteins.
    Fernandes J; Alaupovic P; Wit JM
    Pediatr Res; 1989 Apr; 25(4):327-31. PubMed ID: 2542871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I).
    Rake JP; Visser G; Labrune P; Leonard JV; Ullrich K; Smit GP
    Eur J Pediatr; 2002 Oct; 161 Suppl 1():S20-34. PubMed ID: 12373567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemorrhage into a hepatic adenoma and type Ia glycogen storage disease: a case report and review of the literature.
    Fink AS; Appelman HD; Thompson NW
    Surgery; 1985 Jan; 97(1):117-24. PubMed ID: 3855331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen storage disease type I. Results of treatment with frequent daytime feeding, combined with nocturnal intragastric feeding and with administration of an alpha-glucosidase inhibitor.
    Gröbe H; Ullrich K
    Eur J Pediatr; 1983 Apr; 140(2):102-4. PubMed ID: 6411473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular adenoma and metabolic balance in patients with type Ia glycogen storage disease.
    Di Rocco M; Calevo MG; Taro' M; Melis D; Allegri AE; Parenti G
    Mol Genet Metab; 2008 Apr; 93(4):398-402. PubMed ID: 18083610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma in glycogen storage disease type Ia: a case series.
    Franco LM; Krishnamurthy V; Bali D; Weinstein DA; Arn P; Clary B; Boney A; Sullivan J; Frush DP; Chen YT; Kishnani PS
    J Inherit Metab Dis; 2005; 28(2):153-62. PubMed ID: 15877204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of continuous glucose therapy begun in infancy on the long-term clinical course of patients with type I glycogen storage disease.
    Wolfsdorf JI; Crigler JF
    J Pediatr Gastroenterol Nutr; 1999 Aug; 29(2):136-43. PubMed ID: 10435649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical growth and development of children with type 1 glycogen-storage disease: comparison of the effects of long-term use of dextrose and uncooked cornstarch.
    Wolfsdorf JI; Rudlin CR; Crigler JF
    Am J Clin Nutr; 1990 Dec; 52(6):1051-7. PubMed ID: 2239780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease.
    Greene HL; Slonim AE; O'Neill JA; Burr IM
    N Engl J Med; 1976 Feb; 294(8):423-5. PubMed ID: 813144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease.
    Weinstein DA; Wolfsdorf JI
    Eur J Pediatr; 2002 Oct; 161 Suppl 1():S35-9. PubMed ID: 12373568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen storage disease type Ia: linkage of glucose, glycogen, lactic acid, triglyceride, and uric acid metabolism.
    Sever S; Weinstein DA; Wolfsdorf JI; Gedik R; Schaefer EJ
    J Clin Lipidol; 2012; 6(6):596-600. PubMed ID: 23312056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dietary management of hepatic glycogen storage disease.
    Leonard JV; Francis DE; Dunger DB
    Proc Nutr Soc; 1979 Dec; 38(3):321-4. PubMed ID: 294590
    [No Abstract]   [Full Text] [Related]  

  • 14. Natural history of hepatocellular adenoma formation in glycogen storage disease type I.
    Wang DQ; Fiske LM; Carreras CT; Weinstein DA
    J Pediatr; 2011 Sep; 159(3):442-6. PubMed ID: 21481415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of proximal renal tubular dysfunction in type I glycogen storage disease with dietary therapy.
    Chen YT; Scheinman JI; Park HK; Coleman RA; Roe CR
    N Engl J Med; 1990 Aug; 323(9):590-3. PubMed ID: 2199830
    [No Abstract]   [Full Text] [Related]  

  • 16. The regulation of growth in glycogen storage disease type 1.
    Mundy HR; Hindmarsh PC; Matthews DR; Leonard JV; Lee PJ
    Clin Endocrinol (Oxf); 2003 Mar; 58(3):332-9. PubMed ID: 12608939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I glycogen storage disease: favourable outcome on a strict management regimen avoiding increased lactate production during childhood and adolescence.
    Däublin G; Schwahn B; Wendel U
    Eur J Pediatr; 2002 Oct; 161 Suppl 1():S40-5. PubMed ID: 12373569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intragastric feeding in type I glycogen storage disease: factors affecting the control of lactic acidemia.
    Stanley CA; Mills JL; Baker L
    Pediatr Res; 1981 Dec; 15(12):1504-8. PubMed ID: 6798537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability of renal length in type I glycogen storage disease.
    Chen YT; Feinstein KA; Coleman RA; Effmann EL
    J Inherit Metab Dis; 1990; 13(3):259-62. PubMed ID: 2122080
    [No Abstract]   [Full Text] [Related]  

  • 20. [Home treatment of type I glycogenosis by continuous nocturnal gastric feeding].
    Chouraqui JP; Leluyer B
    Presse Med; 1986 Sep; 15(30):1405-8. PubMed ID: 2947059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.